Cerebrospinal fluid metagenomics has greatest added value as a test for Powassan virus among patients in New England with suspected central nervous system infection
- 4 January 2024
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 108 (4) , 116169
Abstract
No abstract availableKeywords
Funding Information
- Analog Devices
This publication has 7 references indexed in Scilit:
- Fatal Powassan virus encephalitis in patients with chronic lymphocytic leukemiaBlood Cancer Journal, 2022
- Powassan Virus EncephalitisInfectious Disease Clinics of North America, 2022
- A consensus conference to define the utility of advanced infectious disease diagnostics in solid organ transplant recipientsAmerican Journal of Transplantation, 2022
- Direct Metagenomic Diagnosis of Community-Acquired Meningitis: State of the ArtFrontiers in Microbiology, 2022
- Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and EncephalitismBio, 2021
- Clinical Metagenomic Sequencing for Diagnosis of Meningitis and EncephalitisNew England Journal of Medicine, 2019
- Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluidGenome Research, 2019